{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:49:16Z","timestamp":1776775756280,"version":"3.51.2"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.eplepsyres.2009.09.008","type":"journal-article","created":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T07:23:58Z","timestamp":1255073038000},"page":"89-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Antiepileptic drugs and hormones in children"],"prefix":"10.1016","volume":"89","author":[{"given":"Ali","family":"Cansu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2009.09.008_bib1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.63.10_suppl_4.S3","article-title":"Pharmacogenetics and enzyme induction\/inhibition properties of antiepileptic drugs","volume":"63","author":"Anderson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/WNF.0b013e318166cbcd","article-title":"Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study","volume":"32","author":"Attilakos","year":"2009","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib3","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/08830738050200101501","article-title":"Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate","volume":"20","author":"Aydin","year":"2005","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00228-005-0056-0","article-title":"Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction","volume":"61","author":"Benedetti","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1167.2007.01402.x","article-title":"Weight issues for people with epilepsy\u2014a review","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00023210-200317110-00002","article-title":"Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy","volume":"17","author":"Biton","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib7","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/00207450390232300","article-title":"Evaluation of thyroid and parathyroid functions in children receiving long-term carbamazepine therapy","volume":"113","author":"Caksen","year":"2003","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib8","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/j.1528-1167.2006.00821.x","article-title":"The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate","volume":"47","author":"Cansu","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib9","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1528-1167.2008.01576.x","article-title":"Effects of chronic treatment with valproate and oxcarbazepine on ovarian folliculogenesis in rats","volume":"49","author":"Cansu","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.pediatrneurol.2008.07.001","article-title":"Evaluation of bone turnover in epileptic children using oxcarbazepine","volume":"39","author":"Cansu","year":"2008","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pediatrneurol.2007.07.003","article-title":"Evolution of subclinical hypothyroidism in children treated with antiepileptic drugs","volume":"37","author":"Castro-Gago","year":"2007","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib12","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/j.1528-1167.2009.02082.x","article-title":"Bone mineral density in children, adolescents, and young adults with epilepsy","volume":"50","author":"Coppola","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0317167100021879","article-title":"Weight gain in epileptic patients during treatment with valproic acid: a retrospective study","volume":"24","author":"Corman","year":"1997","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1528-1167.2006.00953.x","article-title":"Endocrine effects of valproate in adolescent girls with epilepsy","volume":"48","author":"de Vries","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0887-8994(00)00133-8","article-title":"Weight gain associated with valproate in childhood","volume":"22","author":"Demir","year":"2000","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib16","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1528-1157.1999.tb01595.x","article-title":"Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism","volume":"40","author":"Eiris-Punal","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1528-1157.2003.26502.x","article-title":"Physical and hormonal profile of male sexual development in epilepsy","volume":"44","author":"El-Khayat","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.0013-9580.2004.66303.x","article-title":"Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy","volume":"45","author":"El-Khayat","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1515\/JPEM.2000.13.7.933","article-title":"Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid","volume":"13","author":"Erbayat Altay","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib20","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/WNL.58.9.1348","article-title":"Effect of antiepileptic drugs on bone density in ambulatory patients","volume":"58","author":"Farhat","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib21","first-page":"37","article-title":"Long-term anticonvulsant therapy leads to low bone mineral density\u2014evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells","volume":"108","author":"Feldkamp","year":"2000","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib22","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1177\/0883073807307096","article-title":"The role of ghrelin in weight gain and growth in epileptic children using valproate","volume":"22","author":"Gungor","year":"2007","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib23","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1046\/j.1528-1157.2001.416800.x","article-title":"Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy","volume":"42","author":"Guo","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/00003495-197612030-00003","article-title":"Bone complications of anticonvulsants","volume":"12","author":"Hahn","year":"1976","journal-title":"Drugs"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.eplepsyres.2005.08.004","article-title":"Serum thyroid hormone balance and lipid profile in patients with epilepsy","volume":"66","author":"Hamed","year":"2005","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.10732","article-title":"Interictal EEG discharges, reproductive hormones, and menstrual disorders in epilepsy","volume":"54","author":"Herzog","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.seizure.2007.11.025","article-title":"Disorders of reproduction in patients with epilepsy: primary neurological mechanisms","volume":"17","author":"Herzog","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1442-200X.2007.02456.x","article-title":"Thyroid function and volume in epileptic children using carbamazepine, oxcarbazepine and valproate","volume":"49","author":"Hirfanoglu","year":"2007","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib29","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1528-1157.1990.tb05500.x","article-title":"Serum steroid hormones and pituitary function in female epileptic patients during carbamazepine therapy","volume":"31","author":"Isojarvi","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib30","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM199311043291904","article-title":"Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy","volume":"329","author":"Isojarvi","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib31","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1528-1157.1995.tb01011.x","article-title":"Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsy","volume":"36","author":"Isojarvi","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.seizure.2007.11.007","article-title":"Disorders of reproduction in patients with epilepsy: antiepileptic drug related mechanisms","volume":"17","author":"Isojarvi","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib33","first-page":"115","article-title":"Changes of event related potential and cognitive processes in patients with subclinical hypothyroidism after thyroxine treatment","volume":"36","author":"Jensovsky","year":"2002","journal-title":"Endocr. Regul."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/088307389701200810","article-title":"Adult height and target height in 111 boys and 98 girls treated for epilepsy during childhood","volume":"12","author":"Kurlemann","year":"1997","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib35","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1651-2227.2009.01349.x","article-title":"Effects of topiramate on weight and metabolism in children with epilepsy","volume":"98","author":"Li","year":"2009","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0920-1211(01)00317-5","article-title":"Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate","volume":"48","author":"Luef","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yebeh.2009.02.022","article-title":"Epilepsy and hormones: a critical review","volume":"15","author":"Luef","year":"2009","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.0013-9580.2004.04604.x","article-title":"Serum androgen levels and testicular structure during pubertal maturation in male subjects with epilepsy","volume":"45","author":"Mikkonen","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/01.WNL.0000106942.35533.62","article-title":"Long-term reproductive endocrine health in young women with epilepsy during puberty","volume":"62","author":"Mikkonen","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib40","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1528-1167.2005.34304.x","article-title":"Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation","volume":"46","author":"Mikkonen","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib41","first-page":"367","article-title":"Subclinical hypothyroidism: neurobehavioral features and beneficial effect of l-thyroxine treatment","volume":"71","author":"Monzani","year":"1993","journal-title":"Clin. Invest."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib42","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.21411","article-title":"Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine","volume":"64","author":"Morrell","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib43","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00431-008-0672-7","article-title":"Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy","volume":"167","author":"Nettekoven","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib44","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1440-1754.2004.00431.x","article-title":"Bone mineral metabolism changes in epileptic children receiving valproic acid","volume":"40","author":"Oner","year":"2004","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0002-9343(61)90099-7","article-title":"The syndrome of iodide-induced goiter and myxedema","volume":"30","author":"Oppenheimer","year":"1961","journal-title":"Am. J. Med."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib46","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.3949\/ccjm.71.Suppl_2.S42","article-title":"Bone disease associated with antiepileptic drugs","volume":"71","author":"Pack","year":"2004","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.seizure.2007.11.020","article-title":"Bone health in people with epilepsy: is it impaired and what are the risk factors?","volume":"17","author":"Pack","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib48","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1542\/peds.103.3.588","article-title":"The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy","volume":"103","author":"Rattya","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib49","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/WNL.57.3.440","article-title":"Early hormonal changes during valproate or carbamazepine treatment: a 3-month study","volume":"57","author":"Rattya","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.56.1.31","article-title":"Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy","volume":"56","author":"Rattya","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eplepsyres.2008.03.017","article-title":"Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children","volume":"80","author":"Rauchenzauner","year":"2008","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib52","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1590\/S0021-75572007000700013","article-title":"Hypothyroidism in children: diagnosis and treatment","volume":"83","author":"Setian","year":"2007","journal-title":"J. Pediatr. (Rio J)"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib53","first-page":"189","article-title":"Effects of chronic anticonvulsant monotherapy on endocrine system in prepubertal children with convulsive disorders Preliminary data","volume":"61","author":"Specchio","year":"1985","journal-title":"Boll. Soc. Ital. Biol. Sper."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib54","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000120309","article-title":"Thyroid function in children with long-term anticonvulsant treatment","volume":"13","author":"Tanaka","year":"1987","journal-title":"Pediatr. Neurosci."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib55","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/08830738060210050101","article-title":"Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy","volume":"21","author":"Tekgul","year":"2006","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib56","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-2008-1079336","article-title":"Adverse effects of antiepileptic drugs","volume":"28","author":"Toledano","year":"2008","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1442-200X.2002.01561.x","article-title":"Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy","volume":"44","author":"Tsukahara","year":"2002","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib58","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/1531-8249(199904)45:4<444::AID-ANA5>3.0.CO;2-6","article-title":"Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy","volume":"45","author":"Vainionpaa","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib59","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.0013-9580.2004.26003.x","article-title":"Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication","volume":"45","author":"Vainionpaa","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib60","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s004310000590","article-title":"Serum sex hormone levels in young male patients with epilepsy receiving carbamazepine and valproic acid and after their withdrawal","volume":"159","author":"Verrotti","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0887-8994(01)00279-X","article-title":"Thyroid hormones in epileptic children receiving carbamazepine and valproic acid","volume":"25","author":"Verrotti","year":"2001","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib62","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/088307380201700405","article-title":"Insulin resistance in epileptic girls who gain weight after therapy with valproic acid","volume":"17","author":"Verrotti","year":"2002","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib63","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1046\/j.1528-1157.2002.13002.x","article-title":"Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine","volume":"43","author":"Verrotti","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.09.008_bib64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1530\/EJE-08-0325","article-title":"Thyroid hormones in children with epilepsy during long-term administration of carbamazepine and valproate","volume":"160","author":"Verrotti","year":"2009","journal-title":"Eur. J. Endocrinol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121109002526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121109002526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:22:56Z","timestamp":1760275376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121109002526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0920121109002526"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2009.09.008","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiepileptic drugs and hormones in children","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2009.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}